Hans Peter Hasler

CIK: 0001226286

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

GANX

Gain Therapeutics, Inc.

Director

NERV

Minerva Neurosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

GANX
Gain Therapeutics, Inc.
Jul 15, 2026
Award(A)
Stock Option (right to buy)
Direct
25K shares-
NERV
Minerva Neurosciences, Inc.
Jun 3, 2026
Award(A)
Stock Option (right to buy)
Direct
50K shares-
NERV
Minerva Neurosciences, Inc.
Dec 22, 2025
Award(A)
Stock Option (right to buy)
Direct
50K shares-
GANX
Gain Therapeutics, Inc.
Jun 24, 2025
Award(A)
Stock Option (right to buy)
Direct
15K shares-
NERV
Minerva Neurosciences, Inc.
Dec 5, 2024
Award(A)
Stock Option (right to buy)
Direct
12.5K shares-

		Type	Shares	Price		Ownership
Jul 15, 2026	GANX Gain Therapeutics, Inc.	Award(A) Stock Option (right to buy)	25,000	-	-	Direct
Jun 3, 2026	NERV Minerva Neurosciences, Inc.	Award(A) Stock Option (right to buy)	50,000	-	-	Direct
Dec 22, 2025	NERV Minerva Neurosciences, Inc.	Award(A) Stock Option (right to buy)	50,000	-	-	Direct
Jun 24, 2025	GANX Gain Therapeutics, Inc.	Award(A) Stock Option (right to buy)	15,000	-	-	Direct
Dec 5, 2024	NERV Minerva Neurosciences, Inc.	Award(A) Stock Option (right to buy)	12,500	-	-	Direct

1-5 of 5 transactions

About HASLER HANS PETER

HASLER HANS PETER (SEC CIK 0001226286) files insider reports with the SEC as Director of Gain Therapeutics, Inc. (GANX) and Director of Minerva Neurosciences, Inc. (NERV).

Signal8 holds 5 ownership filings by HASLER HANS PETER, all Form 4s, filed between Dec 6, 2024 and Jul 17, 2026. Those filings report 5 transactions, from Dec 5, 2024 to Jul 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on HASLER HANS PETER's filings is in BETHESDA, MD.

Recent filings by HASLER HANS PETER

Jul 15, 2026: Grant or award of GANX derivative securities (Form 4, code A).
Jun 3, 2026: Grant or award of NERV derivative securities (Form 4, code A).
Dec 22, 2025: Grant or award of NERV derivative securities (Form 4, code A).
Jun 24, 2025: Grant or award of GANX derivative securities (Form 4, code A).
Dec 5, 2024: Grant or award of NERV derivative securities (Form 4, code A).

Other insiders filing for Gain Therapeutics, Inc. (GANX)

How to read Form 4 transaction codes